Cancer of the Pancreas - Cancer Stat Facts, SEER (n.d.). https://seer.cancer.gov/statfacts/html/pancreas.html (accessed March 8, 2023).

M. Ducreux, A.S. Cuhna, C. Caramella, A. Hollebecque, P. Burtin, D. Goéré, T. Seufferlein, K. Haustermans, J.L. Van Laethem, T. Conroy, D. Arnold, Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†, Ann. Oncol. 26 (2015) v56–v68.

Article  PubMed  Google Scholar 

J.D. Mizrahi, R. Surana, J.W. Valle, R.T. Shroff, Pancreatic cancer, Lancet 395 (2020) 2008–2020.

Article  CAS  PubMed  Google Scholar 

M. Suker, B.R. Beumer, E. Sadot, L. Marthey, J.E. Faris, E.A. Mellon, B.F. El-Rayes, A. Wang-Gillam, J. Lacy, P.J. Hosein, S.Y. Moorcraft, T. Conroy, F. Hohla, P. Allen, J. Taieb, T.S. Hong, R. Shridhar, I. Chau, C.H. van Eijck, B.G. Koerkamp, FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis, Lancet Oncol. 17 (2016) 801–810.

Article  CAS  PubMed  PubMed Central  Google Scholar 

E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur. J. Cancer 45 (2009) 228–247.

C. Cassinotto, A. Mouries, J.-P. Lafourcade, E. Terrebonne, G. Belleannée, J.-F. Blanc, B. Lapuyade, V. Vendrely, C. Laurent, L. Chiche, T. Wagner, A. Sa-Cunha, D. Gaye, H. Trillaud, F. Laurent, M. Montaudon, Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy, Radiology 273 (2014) 108–116.

Article  PubMed  Google Scholar 

M. Wagner, C. Antunes, D. Pietrasz, C. Cassinotto, M. Zappa, A. Sa Cunha, O. Lucidarme, J.-B. Bachet, CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma, Eur. Radiol. 27 (2017) 3104–3116.

S.-S. Kim, S. Lee, H. Seung Lee, S. Bang, K. Han, M.-S. Park, Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19–9, Radiology (2022) 212236.

S.M. Lee, M.H.G. Katz, L. Liu, M. Sundar, H. Wang, G.R. Varadhachary, R.A. Wolff, J.E. Lee, A. Maitra, J.B. Fleming, A. Rashid, H. Wang, Validation of a proposed tumor regression grading scheme for pancreatic ductal adenocarcinoma after neoadjuvant therapy as a prognostic indicator for survival, Am. J. Surg. Pathol. 40 (2016) 1653–1660.

Article  PubMed  PubMed Central  Google Scholar 

S.G. Barreto, B. Loveday, J.A. Windsor, S. Pandanaboyana, Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer, ANZ J. Surg. 89 (2019) 481–487.

Article  PubMed  Google Scholar 

T. Conroy, P. Pfeiffer, V. Vilgrain, A. Lamarca, T. Seufferlein, E.M. O’Reilly, T. Hackert, T. Golan, G. Prager, K. Haustermans, A. Vogel, M. Ducreux, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org, Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, Ann. Oncol. 34 (2023) 987–1002.

A. Tsen, M. Barbara, L. Rosenkranz, Dilemma of elevated CA 19-9 in biliary pathology, Pancreatology 18 (2018) 862–867.

Article  CAS  PubMed  Google Scholar 

D. Tamburrino, C. Arcangeli, F. De Stefano, G. Belfiori, M. Macchini, G. Orsi, M. Schiavo Lena, S. Partelli, S. Crippa, C. Doglioni, M. Reni, M. Falconi, Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence, Surgery 176 (2024) 1458–1465.

L. Preda, S.F. Calloni, M.E.M. Moscatelli, M. Cossu Rocca, M. Bellomi, Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinoma, Biomed Res. Int. 2014 (2014) 917150.

R. García-Figueiras, V.J. Goh, A.R. Padhani, S. Baleato-González, M. Garrido, L. León, A. Gómez-Caamaño, CT perfusion in oncologic imaging: a useful tool?, AJR Am. J. Roentgenol. 200 (2013) 8–19.

Article  PubMed  Google Scholar 

M.-S. Park, Perfusion CT: Noninvasive Surrogate Marker for Stratification of Pancreatic Cancer Response to Concurrent Chemo- and Radiation Therapy1, Radiology 250 (2009).

A. Hamdy, Y. Ichikawa, Y. Toyomasu, M. Nagata, N. Nagasawa, Y. Nomoto, H. Sami, H. Sakuma, Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience, Radiology 292 (2019) 628–635.

Article  PubMed  Google Scholar 

R.B. O’Malley, E.V. Soloff, A.L. Coveler, D.H. Cox, N. Desai, J.M. Busey, G.M. Valentin, C.L. Wang, Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma, Abdom Radiol (NY) 46 (2021) 1992–2002.

Article  PubMed  Google Scholar 

T.H. Perik, E.A.J. van Genugten, E.H.J.G. Aarntzen, E.J. Smit, H.J. Huisman, J.J. Hermans, Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review, Abdom Radiol (NY) 47 (2022) 3101–3117.

Article  CAS  PubMed  Google Scholar 

T. Perik, N. Alves, J.J. Hermans, H. Huisman, Automated Quantitative Analysis of CT Perfusion to Classify Vascular Phenotypes of Pancreatic Ductal Adenocarcinoma, Cancers 16 (2024) 577.

Article  PubMed  PubMed Central  Google Scholar 

N. Alves, M. Schuurmans, G. Litjens, J.S. Bosma, J. Hermans, H. Huisman, Fully Automatic Deep Learning Framework for Pancreatic Ductal Adenocarcinoma Detection on Computed Tomography, Cancers 14 (2022). https://doi.org/10.3390/cancers14020376.

D. Doppenberg, J.L. van Dam, Y. Han, B.A. Bonsing, O.R. Busch, S. Festen, E. van der Harst, I.H. de Hingh, M.Y.V. Homs, W. Kwon, M. Lee, D.J. Lips, V.E. de Meijer, I.Q. Molenaar, J.J. Nuyttens, G.A. Patijn, S. van Roessel, G.P. van der Schelling, M. Suker, E. Versteijne, J. de Vos-Geelen, J.W. Wilmink, C.H.J. van Eijck, G. van Tienhoven, J.-Y. Jang, M.G. Besselink, B. Groot Koerkamp, Dutch Pancreatic Cancer Group, Predictive value of baseline serum carbohydrate antigen 19–9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials - PMC, Br. J. Surg. 110 (2023) 1374–1380.

D.B. Evans, T.A. Rich, D.R. Byrd, K.R. Cleary, J.H. Connelly, B. Levin, C. Charnsangavej, C.J. Fenoglio, F.C. Ames, Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas, Arch. Surg. 127 (1992) 1335–1339.

Article  CAS  PubMed  Google Scholar 

J.L. van Dam, E.M.M. Verkolf, E.N. Dekker, B.A. Bonsing, S.O. Bratlie, L.A.A. Brosens, O.R. Busch, L.M.J.W. van Driel, C.H.J. van Eijck, S. Feshtali, P. Ghorbani, D.J.A. de Groot, J.W.B. de Groot, B.C.M. Haberkorn, I.H. de Hingh, B. van der Holt, T.M. Karsten, M.B. van der Kolk, K.J. Labori, M.S.L. Liem, O.J.L. Loosveld, I.Q. Molenaar, M.B. Polée, H.C. van Santvoort, J. de Vos-Geelen, M.L. Wumkes, G. van Tienhoven, M.Y.V. Homs, M.G. Besselink, J.W. Wilmink, B. Groot Koerkamp, Dutch Pancreatic Cancer Group, Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial, BMC Cancer 23 (2023) 728.

C. Verbeke, M. Löhr, J.S. Karlsson, M. Del Chiaro, Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties, Cancer Treat. Rev. 41 (2015) 17–26.

Article  CAS  PubMed  Google Scholar 

C.-C. Ko, L.-R. Yeh, Y.-T. Kuo, J.-H. Chen, Imaging biomarkers for evaluating tumor response: RECIST and beyond, Biomark Res 9 (2021) 52.

Article  PubMed  PubMed Central  Google Scholar